REFERENCES
- Altman, D. G., Bland, J. M. (1995). Absence of evidence is not evidence of absence. British Medical Journal 311:485.
- Anderson, T. W. (1984). An Introduction to Multivariate Statistical Analysis. Second Edition. New York, NY: John Wiley & Sons.
- Boente, G., Farall, A. (2008). Robust multivariate tolerance regions: Influence function and Monte Carlo study. Technometrics 50(4):487–500.
- Chervoneva, I., Hyslop, T., Hauck, W. W. (2007). A multivariate test for population bioequivalence. Statistics in Medicine 26(6):1208–1223.
- Chow, S. C., Fanny, Y. K. (1997). Statistical comparison between dissolution profiles of drug products. Journal of Biopharmaceutical Statistics 7(2):241–258.
- Chow, S. C., Liu, J. (2000). Design and Analysis of Bioavailability and Bioequivalence Studies. New York, NY: Marcel Dekker.
- European Medicines Agency EMA (2010). Guideline on the Investigation of Bioequivalence. London, UK: European Medicines Agency, CHMP.
- Food and Drug Administration FDA (1997). Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, CDER.
- Food and Drug Administration FDA (2004). Guidance for Industry: Changes to an Approved NDA or ANDA. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, CDER.
- Giani, G., Finner, H. (1991). Some general results on least favorable parameter configurations with special reference to equivalence testing and the range statistic. Journal of Statistical Planning and Inference 28(1):33–47.
- Hoffelder, T. (2006). Multivariate Zweistichprobentests auf Äquivalenz für normalverteilte Daten. Diploma thesis, Department of Physics, Mathematics and Computer Sciences, Johannes Gutenberg University Mainz.
- Kotz, S., Johnson, N. L. (2002). Process capability indices – a review. Journal of Quality Technology 34:2–19.
- Krishnamoorthy, K., Mathew, T. (1999). Comparison of approximation methods for computing tolerance factors for a multivariate normal population. Technometrics 41:234–249.
- Lachenbruch, P. A., Rida, W., Kou, J. (2004). Lot consistency as an equivalence problem. Journal of Biopharmaceutical Statistics 14(2):275–290.
- Lehmann, E. L., Casella, G. (1998). Theory of Point Estimation. Springer texts in statistics. New York, NY: Springer.
- Liu, J.-P., Ma, M.-C., Chow, S.-C. (1997). Statistical evaluation of similarity factor f2 as a criterion for assessment of similarity between dissolution profiles. Drug Information Journal 31(1):1255–1271.
- Lowry, C. A., Woodall, W. H. (1992). A multivariate exponentially weighted moving average control chart. Technometrics 34:46–53.
- Ma, M. C., Lin, R. P., Liu, J. P. (2000a). Statistical evaluations of dissolution similarity. Statistica Sinica 9(4):1011–1028.
- Ma, M. C., Wang, B. B. C., Liu, J. P., Tsong, Y. (2000b). Assessment of similarity between dissolution profiles. Journal of Biopharmaceutical Statistics 10(2):229–249.
- Montgomery, D. C. (2008). Introduction to Statistical Quality Control. New York, NY: John Wiley & Sons.
- Moore, J. W., Flanner, H. H. (1996). Mathematical comparison of dissolution profiles. Pharmaceutical Technology 20:64–74.
- Munk, A., Pflüger, R. (1999). 1-α equivariant confidence rules for convex alternatives are α/2-level tests – with applications to the multivariate assessment of bioequivalence. Journal of the American Statistical Association 94(448):1311–1319.
- Rao, C. R. (1973). Linear Statistical Inference and Its Applications. Second Edition. Wiley Series in Probability and Mathematical Statistics: Probability and Mathematical Statistics. New York, NY: John Wiley & Sons.
- Reiser, B. (2001). Confidence intervals for the mahalanobis distance. Communications in Statistics – Simulation and Computation 30(1):37–45.
- Ryan, T. P. (2000). Statistical Methods for Quality Improvement. New York, NY: John Wiley & Sons.
- Saranadasa, H. (2001). Defining similarity of dissolution profiles through Hotelling’s T2 statistic. Pharmaceutical Technology 24:46–54.
- Saranadasa, H., Krishnamoorthy, K. (2005). A multivariate test for similarity of two dissolution profiles. Journal of Biopharmaceutical Statistics 15(2):265–278.
- Shah, V. P., Tsong, Y., Sathe, P., Liu, J. P. (1998). In vitro dissolution profile comparison–statistics and analysis of the similarity factor, f2. Pharmaceutical Research 15(6):889–896.
- Tsong, Y., Hammerstrom, T., Sathe, P., Shah, V. P. (1996). Statistical assessment of mean differences between two dissolution data sets. Drug Information Journal 30(4):1105–1112.
- Tsong, Y., Sathe, P. M., Shah, V. P. (2003). In vitro dissolution profile comparison. In Chow, S.-C., editor, Encyclopedia of Biopharmaceutical Statistics. Second Edition, Revised and Expanded, pages 456–462. New York, NY: Marcel Dekker.
- Tsong, Y., Zhong, J. (2010). Multiple comparisons of repeated measured response: Issues of assessment of prolongation of QT interval in thorough QT trials. Journal of Biopharmaceutical Statistics 20(3):613–623.
- Wellek, S. (1993). A log-rank test for equivalence of two survivor functions. Biometrics 49:877–881.
- Wellek, S. (1996). A new approach to equivalence assessment in standard comparative bioavailability trials by means of the Mann–Whitney statistic. Biometrical Journal 38:695–710.
- Wellek, S. (2010). Testing Statistical Hypotheses ofEquivalence and Noninferiority. Second Edition. Boca Raton, FL: Chapman & Hall / CRC Press LLC.
- Wellek, S., Michaelis, J. (1991). Elements of significance testing with equivalence problems. Methods of Information in Medicine 30:194–198.
- Wiens, B. L., Iglewicz, B. (1999). On testing equivalence of three populations. Journal of Biopharmaceutical Statistics 9(3):465–483.
- Wiens, B. L., Iglewicz, B. (2000). Design and analysis of three treatment equivalence trials. Controlled Clinical Trials 21(2):127–137.